Sign in
AKLI Stock Price, Chart, Stats & News
Akili, Inc.
Save
34.10M
Market cap
–
Current P/E
–
Forward P/E
AKLI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 51.19% |
Operating margin | -3842.97% |
Pretax margin | -3545.47% |
Net margin | -3545.47% |
Effective tax rate | – |
ROA | -74.01% |
ROE | -70.32% |
D/E | 0.26x |
Interest coverage ratio | -27.35x |
AKLI valuation
P/E | – |
P/S | 20.32x |
P/B | 0.58x |
P/CF | -0.59x |
P/FCF | -0.59x |
P/OCF | -0.59x |
PEG | -0.01x |
EV multiple | -1.66x |
About
Akili, Inc. is a digital medicine enterprise focused on developing innovative digital therapies for individuals experiencing cognitive impairments. Its flagship product, EndeavorRx, stands out as a unique video game-based treatment that necessitates a physician's prescription and is specifically engineered to directly target and improve cognitive functioning. This company operates from its headquarters in Boston, Massachusetts.
Similar securities
Based on sector and market capitalization
Report issue